GlycoLog
En vente sur le marché américain (selon le DSLD)
Blackstone Labs, food supplement from the US market
GlycoLog (Blackstone Labs), a food supplement au code-barres 636823236519, is described by its US market label. If sold in France, it would be subject to 1 point of French or European regulation, detailed below. The formula sold in Europe under the same name may differ.
Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
If this product were sold in France
- Dose déclarée au-delà d'une limite
Chrome: up to 600 µg a day according to the label (at most 2 servings a day), above the maximum dose of 25 µg set in France for a food supplement (2006 Order, not revised since November 2006).
Source: French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), arrêté du 9 mai 2006, annexe III.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- Blackstone Labs
- Barcode
- 636823236519
- Form
- Capsule
- One serving
- 3 capsules
- Servings
- up to 2 servings per day
- Other ingredients (in English, as written)
- Gelatin, Magnesium Stearate, Silicon Dioxide, Titanium Dioxide
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Chromium | Mineral | 300 µg |
| Gymnema extract (Gymnema sylvestre) | Plant | 1,000 mg |
| Bitter Melon (Momordica charantia) | Plant | 500 mg |
| Super Berberine | Other substance | 300 mg |
| Cinnamon extract (Cinnamomum verum) | Plant | 250 mg |
| Sodium R-Lipoate | Other substance | 150 mg |
| BioPerine Black Pepper (fruit) extract (Piper nigrum) | Plant | 5 mg |
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: GlycoLog
Entered into DSLD on 24 July 2019. Retirée du marché américain le 9 August 2021 (selon le DSLD).- Same quantity, different name: BioPerine in this version; BioPerine Black Pepper (fruit) extract on the displayed label (5 mg)
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Cinnamon extract
Read the warning, when it applies and the studies cited
Cinnamon - Cinnamomum Verum
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes (Brinker 2010; Blumenthal et al. 2000; WHO 1999).
3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Condition of application: All products except antioxidants.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Contraindications
Do not use if you are pregnant (Brinker 2010; BHC 2006; Blumenthal 2000).
3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
- Sodium R-Lipoate
Read the warning, when it applies and the studies cited
DL-ALPHA-LIPOIC ACID/R-ALPHA-LIPOIC ACID
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes (Jacob et al. 1999, Konrad et al. 1999, Packer et al. 1995).
3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Applies to products providing 42 milligrams or more DL-alpha-lipoic acid or 21 milligrams or more R-alpha-lipoic acid, per day.
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if you experience sweating, paleness, chills, headache, dizziness and/or confusion (as these may be symptoms of serious low blood sugar) (Bae et al., 2013; Gullo et al., 2014; Bresciani et al., 2011; Chang et al., 2009).
4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Brand : Blackstone Labs
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.